Safety analysis of sofosbuvir and ledipasvir for treating hepatitis C.
about
Combination ledipasvir-sofosbuvir for the treatment of chronic hepatitis C virus infection: a review and clinical perspectiveManagement of immunosuppressant agents following liver transplantation: Less is morePatient-reported and economic outcomes related to sofosbuvir and ledipasvir treatment for chronic hepatitis C.Implementation of baby boomer hepatitis C screening and linking to care in gastroenterology practices: a multi-center pilot studyThe levels of monoamine neurotransmitters and measures of mental and emotional health in HCV patients treated with ledipasvir (LDV) and sofosbuvir (SOF) with or without ribavirin (RBV).Drug interactions in HIV-infected patients treated for hepatitis C.Twelve-week ribavirin-free direct-acting antivirals for treatment-experienced Chinese with HCV genotype 1b infection including cirrhotic patients.Membranous nephropathy associated with hepatitis C virus infection treated with corticosteroids and Ledipasvir-Sofosbuvir: a case report and review of literature.Sexual Dysfunction in a Patient Taking Ledipasvir/Sofosbuvir for the Treatment of Hepatitis C: A Case Report.
P2860
Q26746910-F8640A1E-10ED-4100-8A64-491243C4BC45Q26770033-2B6CCBC0-5DF9-470D-B82E-5C76FBC06952Q30393824-D13770B9-EF7C-48E0-BB2C-97CFE417C41FQ36765588-66CBD047-C105-4B78-81E0-82B280A4DDBBQ37432877-99343672-7BB4-42CB-A26B-F3C26AE78558Q40143109-B64DA8E7-A903-448B-ACDA-8A927B03E004Q40604753-672EA6CA-F9CE-497F-A2A7-B023251FC4F3Q42290798-40A8063C-4A65-43AC-BB83-02AA2AA0132EQ47571985-670428AB-A628-4B10-AB0F-D89575C06F59
P2860
Safety analysis of sofosbuvir and ledipasvir for treating hepatitis C.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Safety analysis of sofosbuvir and ledipasvir for treating hepatitis C.
@en
type
label
Safety analysis of sofosbuvir and ledipasvir for treating hepatitis C.
@en
prefLabel
Safety analysis of sofosbuvir and ledipasvir for treating hepatitis C.
@en
P2093
P2860
P1476
Safety analysis of sofosbuvir and ledipasvir for treating hepatitis C.
@en
P2093
Pegah Golabi
Yousef Fazel
Zobair Younossi
P2860
P304
P356
10.1517/14740338.2015.1053868
P407
P577
2015-06-04T00:00:00Z